Navigate Titan Pharmaceuticals, Inc.
Home
About
Overview
Who We Are
Strategic Alliances
IP Portfolio
Management Team
Board of Directors
Careers
Technology
Pipeline
Overview
Probuphine
Ropinirole Implant
T3 Implant
News
Overview
Press Releases
Events
Presentations
In the News
Publications
Posters
Media Resources
Investors
Investor Relations
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Company Information
Profile
Presentations
Management Team
Contacts
FAQ
Financial Info
Financials
Financial Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Contact
Search
Press Releases
Home
News
Press Releases
News
Navigate News
Overview
Press Releases
Events
Presentations
In the News
Publications
Posters
Media Resources
Press Releases
All News
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Titan Pharmaceuticals Announces Addition Of Probuphine® To Federal Supply Schedule
January 13, 2020
Titan Pharmaceuticals Announces Pricing of $2.2 Million Registered Direct Offering
January 7, 2020
